January 29, 2009

Suntan Drug Greenlighted for Trials

Although the drug will not be available for cosmetic purposes any time soon, similar compounds are already being widely abused on the pharmaceutical black market. The official product, a man made hormone called afamalenodtide, has received U.S. government approval to begin clinical trials.

"It's a bioabsorbable implant that you just inject into the skin," said Colin Mackie, director of business development for Clinuvel, the company bringing the drug to the U.S. "It stimulates melanin production."

Read more.

2 comments:

Anonymous said...

The actual generic name for melanotan one is "afamelanotide". The Wired article has been corrected.
You folks might want to update your blog entry.

ami said...

The "suntan drug" melanotan-1 (afamelanotide / Scenesse) has been approved in Italy as a drug to develop photoprotective pigmentation in those afflicted with the orphan disease erythropoietic protoporphyria. This stimulated pigmentation creates a barrier to block the light rays that cause the painful photosensitivity that these folks experience from the affliction. This is potentially a big first step to making this drug generally available. Here is the news of this development. more info: melanotan-1 Scenesse

Thanks